Enantiomers in pharmaceuticals often have different biological activities
the verdict
SUPPORTED
the evidence backs this
confidence 78/100
Multiple recent pharmaceutical and pharmacological studies confirm that enantiomers frequently exhibit differences in pharmacokinetics, metabolism, and biological or pharmacological activity.
Evidence for · 5
Stereoselectivity of In Vivo Processes and Bioactivity of Farrerol Enantiomers.
2025 · cited by 2
Demonstrates that farrerol enantiomers exhibit stereoselective pharmacokinetics and differences in enzyme inhibition and binding affinity.
See more details
More for · 4
From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications.
2025 · cited by 2
Reviews antiseizure medications and highlights established stereochemical differences in pharmacokinetics and pharmacodynamics between enantiomers.
Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine.
2025 · cited by 1
Observes stereoselective pharmacokinetics and chiral plasma ratio variations in long-term metoprolol therapy.
Stereoselectivity and functional plasticity of a common ligand-binding pocket in TRPM3.
2026 · cited by 0
Shows that TRPM3 channels exhibit distinct stereoselectivity for specific enantiomeric agonists and antagonists.
Enantioselective Complexation of Xylopinine: A Cyclodextrin-Assisted CE and NMR Study.
2025 · cited by 0
Notes that tetrahydroprotoberberine alkaloid enantiomers frequently display enantiomer-specific pharmacological effects.